Clinical AI
AI Imaging Giant Cleerly Adds Genetic Testing to Build Comprehensive Heart Disease Risk Platform
New partnership with Allelica combines polygenic risk scoring with FDA-cleared coronary CT analysis to identify high-risk patients up to two decades earlier than traditional methods.
Health AI Central Editorial Team·July 31, 2026
Clinical AI
How One AI Cardiology Company Is Winning Over Skeptical Clinicians at Major Imaging Conferences
Cleerly's hands-on strategy at SCCT 2026 reveals a blueprint for translating cardiovascular AI from research promise to clinical reality.
Health AI Central Editorial Team·July 26, 2026